David M. Lukac

2.9k total citations
30 papers, 2.4k citations indexed

About

David M. Lukac is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, David M. Lukac has authored 30 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 24 papers in Oncology and 6 papers in Infectious Diseases. Recurrent topics in David M. Lukac's work include Viral-associated cancers and disorders (23 papers), Cytomegalovirus and herpesvirus research (23 papers) and Herpesvirus Infections and Treatments (12 papers). David M. Lukac is often cited by papers focused on Viral-associated cancers and disorders (23 papers), Cytomegalovirus and herpesvirus research (23 papers) and Herpesvirus Infections and Treatments (12 papers). David M. Lukac collaborates with scholars based in United States, Bulgaria and France. David M. Lukac's co-authors include Don Ganem, Jessica R. Kirshner, Diana Palmeri, Rolf Renne, James C. Alwine, Jean Chang, Jonathan C. Guito, Assen L. Dourmishev, Lyubomir Dourmishev and Robert A. Schwartz and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Journal of Virology.

In The Last Decade

David M. Lukac

29 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Lukac United States 22 1.9k 1.9k 357 311 294 30 2.4k
Nancy W. Abbey United States 15 1.2k 0.6× 883 0.5× 486 1.4× 272 0.9× 202 0.7× 20 1.9k
D M Ciufo United States 16 1.4k 0.7× 1.3k 0.7× 426 1.2× 178 0.6× 347 1.2× 19 1.9k
Hiroki Isomura Japan 28 1.1k 0.6× 1.3k 0.7× 211 0.6× 602 1.9× 111 0.4× 52 2.1k
Henri Gruffat France 33 1.7k 0.9× 1.0k 0.5× 452 1.3× 693 2.2× 257 0.9× 67 2.6k
Roy A. Bohenzky United States 11 2.5k 1.3× 2.0k 1.0× 891 2.5× 326 1.0× 536 1.8× 12 3.1k
Ayumi Kudoh Japan 26 975 0.5× 847 0.4× 190 0.5× 540 1.7× 106 0.4× 35 1.7k
Fanxiu Zhu United States 24 1.1k 0.6× 1.1k 0.6× 487 1.4× 686 2.2× 155 0.5× 45 2.2k
Pramod P. Naranatt United States 11 978 0.5× 861 0.5× 149 0.4× 232 0.7× 125 0.4× 14 1.4k
Brigitte Biesinger Germany 20 1.1k 0.6× 1.2k 0.6× 120 0.3× 193 0.6× 94 0.3× 37 1.8k
John L. Yates United States 20 1.4k 0.7× 888 0.5× 348 1.0× 841 2.7× 108 0.4× 22 2.3k

Countries citing papers authored by David M. Lukac

Since Specialization
Citations

This map shows the geographic impact of David M. Lukac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lukac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lukac more than expected).

Fields of papers citing papers by David M. Lukac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Lukac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lukac. The network helps show where David M. Lukac may publish in the future.

Co-authorship network of co-authors of David M. Lukac

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Lukac. A scholar is included among the top collaborators of David M. Lukac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Lukac. David M. Lukac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Sun M., et al.. (2024). The cellular Notch1 protein promotes KSHV reactivation in an Rta-dependent manner. Journal of Virology. 98(8). e0078824–e0078824.
2.
González‐López, Olga, Hye Jin Shin, Kyla Driscoll, et al.. (2019). A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome. Journal of Biological Chemistry. 294(35). 13073–13092. 5 indexed citations
3.
4.
Lukac, David M., et al.. (2017). KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens. 6(3). 34–34. 11 indexed citations
5.
Guito, Jonathan C. & David M. Lukac. (2015). KSHV Reactivation and Novel Implications of Protein Isomerization on Lytic Switch Control. Viruses. 7(1). 72–109. 28 indexed citations
6.
Shin, Hye Jin, et al.. (2013). Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation. Journal of Virology. 88(2). 1281–1292. 49 indexed citations
7.
Lu, Michael, et al.. (2012). An Alternative Kaposi's Sarcoma-Associated Herpesvirus Replication Program Triggered by Host Cell Apoptosis. Journal of Virology. 86(8). 4404–4419. 25 indexed citations
8.
Guito, Jonathan C. & David M. Lukac. (2012). KSHV Rta Promoter Specification and Viral Reactivation. Frontiers in Microbiology. 3. 30–30. 79 indexed citations
9.
Palmeri, Diana, Kyla Driscoll Carroll, Olga González‐López, & David M. Lukac. (2011). Kaposi's Sarcoma-Associated Herpesvirus Rta Tetramers Make High-Affinity Interactions with Repetitive DNA Elements in the Mta Promoter To Stimulate DNA Binding of RBP-Jk/CSL. Journal of Virology. 85(22). 11901–11915. 18 indexed citations
10.
11.
Bu, Wei, Kyla Driscoll Carroll, Diana Palmeri, & David M. Lukac. (2007). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50/Rta Lytic Switch Protein Functions as a Tetramer. Journal of Virology. 81(11). 5788–5806. 35 indexed citations
12.
13.
Carroll, Kyla Driscoll, Wei Bu, Diana Palmeri, et al.. (2006). Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway. Journal of Virology. 80(19). 9697–9709. 52 indexed citations
14.
Dourmishev, Lyubomir, Assen L. Dourmishev, Diana Palmeri, Robert A. Schwartz, & David M. Lukac. (2003). Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis. Microbiology and Molecular Biology Reviews. 67(2). 175–212. 268 indexed citations
15.
Liang, Yuying, Jean Chang, Stephen J. Lynch, David M. Lukac, & Don Ganem. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway. Genes & Development. 16(15). 1977–1989. 213 indexed citations
16.
Lagunoff, Michael, David M. Lukac, & Don Ganem. (2001). Immunoreceptor Tyrosine-Based Activation Motif-Dependent Signaling by Kaposi's Sarcoma-Associated Herpesvirus K1 Protein: Effects on Lytic Viral Replication. Journal of Virology. 75(13). 5891–5898. 62 indexed citations
17.
Polson, Andrew G., Lan Huang, David M. Lukac, et al.. (2001). Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Phosphorylated by Cyclin-Dependent Kinases. Journal of Virology. 75(7). 3175–3184. 64 indexed citations
18.
Lukac, David M., Jessica R. Kirshner, & Don Ganem. (1999). Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells. Journal of Virology. 73(11). 9348–9361. 335 indexed citations
19.
Lukac, David M., Rolf Renne, Jessica R. Kirshner, & Don Ganem. (1998). Reactivation of Kaposi's Sarcoma-Associated Herpesvirus Infection from Latency by Expression of the ORF 50 Transactivator, a Homolog of the EBV R Protein. Virology. 252(2). 304–312. 373 indexed citations
20.
Griot, Christian, Andrew Pekosz, Richard L. Davidson, et al.. (1994). Replication in Cultured C2C12 Muscle Cells Correlates with the Neuroinvasiveness of California Serogroup Bunyaviruses. Virology. 201(2). 399–403. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy W. Abbey Breakdown of academic impact, for papers by D M Ciufo Breakdown of academic impact, for papers by Hiroki Isomura Breakdown of academic impact, for papers by Henri Gruffat Breakdown of academic impact, for papers by Roy A. Bohenzky Breakdown of academic impact, for papers by Ayumi Kudoh Breakdown of academic impact, for papers by Fanxiu Zhu Breakdown of academic impact, for papers by Pramod P. Naranatt Breakdown of academic impact, for papers by Brigitte Biesinger Breakdown of academic impact, for papers by John L. Yates
Rankless by CCL
2026